Abstract
Regulation of the kinetics of intracellular Ca2+ signals with a novel, membrane-penetrable, inositol 1,4,5-trisphosphate (InsP3) receptor/Ca2+ channel modulator, 2-amino-ethoxydiphenyl borate (2APB), has been investigated using patch-clamp, whole-cell recording to monitor Ca2+-activated Cl− currents in single isolated pancreatic acinar cells. 2APB itself fails to evoke a detectable current response but it dramatically changes the kinetics of agonist-induced Ca2+release from pulsatile spikes to long-lasting, huge Ca2+waves, suggesting that 2APB coordinates local Ca2+ release to generate global Ca2+ signals. The regulation by 2APB can be elicited by internal perfusion of InsP3 in a concentration-dependent manner, indicating that this regulation is not mediated through membrane receptors or G protein signal transduction. The InsP3 receptor blocker heparin, but not the ryanodine-sensitive receptor blockers ruthenium red or ryanodine, abolishes 2APB-mediated regulation of Ca2+ release. This results also suggest that 2APB effects are mediated through InsP3 receptors. 2APB substantially modifies single inward Cl− current pulse evoked by the photolytic release of caged InsP3 but not by caged Ca2+. These data indicate that 2APB-induced regulation is mediated neither by Ca2+-induced Ca2+ release nor by affecting Cl− channel activity directly. We conclude that 2APB regulates the kinetics of intracellular Ca2+ signals, represented as the change in the Ca2+ oscillation patterns from brief pulsatile spikes to huge, long-lasting Ca2+waves. Moreover, this regulation seems to be mediated through InsP3-sensitive Ca2+ pools. 2APB may act as a novel, useful pharmacological tool to study the genesis of intracellular Ca2+ signals.
Footnotes
- Received December 17, 1999.
- Accepted August 9, 2000.
-
Send reprint requests to: Jie Wu, M.D., Ph.D., Division of Neurology, Barrow Neurological Institute, St. Joseph Hospital and Medical Center, 350 West Thomas Road, Phoenix AZ 85013-4496. E-mail:jwu2{at}chw.edu
-
↵1 Present address: Division of Neurology, Barrow Neurological Institute, St. Joseph Hospital and Medical Center, Phoenix, Arizona.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|